Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001209191-22-015722

Director bought 27,708 shares at $1.69 ($46,827)

From the SEC's structured data for this filing

Trades in this filing

HILZINGER KURT J · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-03-01 Purchase : show line 1 in the form +27,708 $1.69 $46,827 273,117 D
Open-market purchases · 27,708 sh · avg $1.69 · $46,827
Loading xslF345X03/doc4.xml…